• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳果糖对腺嘌呤诱导的慢性肾脏病大鼠肾功能和肠道微生物群的影响。

Effects of lactulose on renal function and gut microbiota in adenine-induced chronic kidney disease rats.

机构信息

Department of Clinical Pharmacology, Faculty of Pharmaceutical Sciences, Kumamoto University, 5-1, Oe-Honmachi, Chuo-ku, Kumamoto, 862-0973, Japan.

Pharmaceuticals Research Laboratories, Sanwa Kagaku Kenkyusho Co., Ltd, Mie, Japan.

出版信息

Clin Exp Nephrol. 2019 Jul;23(7):908-919. doi: 10.1007/s10157-019-01727-4. Epub 2019 Mar 20.

DOI:10.1007/s10157-019-01727-4
PMID:30895529
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6555783/
Abstract

BACKGROUND

Constipation is frequently observed in patients with chronic kidney disease (CKD). Lactulose is expected to improve the intestinal environment by stimulating bowel movements as a disaccharide laxative and prebiotic. We studied the effect of lactulose on renal function in adenine-induced CKD rats and monitored uremic toxins and gut microbiota.

METHODS

Wistar/ST male rats (10-week-old) were fed 0.75% adenine-containing diet for 3 weeks to induce CKD. Then, they were divided into three groups and fed as follows: control, normal diet; and 3.0- and 7.5-Lac, 3.0% and 7.5% lactulose-containing diets, respectively, for 4 weeks. Normal diet group was fed normal diet for 7 weeks. The rats were observed for parameters including renal function, uremic toxins, and gut microbiota.

RESULTS

The control group showed significantly higher serum creatinine (sCr) and blood urea nitrogen (BUN) 3 weeks after adenine feeding than at baseline, with a 8.5-fold increase in serum indoxyl sulfate (IS). After switching to 4 weeks of normal diet following adenine feeding, the sCr and BUN in control group remained high with a further increase in serum IS. In addition, tubulointerstitial fibrosis area was increased in control group. On the other hand, 3.0- and 7.5-Lac groups improved sCr and BUN levels, and suppressed tubulointerstitial fibrosis, suggesting preventing of CKD progression by lactulose. Lac groups also lowered level of serum IS and proportions of gut microbiota producing IS precursor.

CONCLUSION

Lactulose modifies gut microbiota and ameliorates CKD progression by suppressing uremic toxin production.

摘要

背景

慢性肾脏病(CKD)患者常出现便秘。乳果糖作为一种二糖泻药和益生元,通过刺激肠道蠕动来改善肠道环境。我们研究了乳果糖对腺嘌呤诱导的 CKD 大鼠肾功能的影响,并监测了尿毒症毒素和肠道微生物群。

方法

Wistar/ST 雄性大鼠(10 周龄)喂食含 0.75%腺嘌呤的饮食 3 周以诱导 CKD。然后,将它们分为三组,分别喂食以下饮食:对照组,正常饮食;3.0-Lac 和 7.5-Lac 组,分别喂食含 3.0%和 7.5%乳果糖的饮食,共 4 周。正常饮食组喂食正常饮食 7 周。观察大鼠的肾功能、尿毒症毒素和肠道微生物群等参数。

结果

对照组在腺嘌呤喂养 3 周后血清肌酐(sCr)和血尿素氮(BUN)显著高于基线,血清吲哚硫酸(IS)增加了 8.5 倍。在腺嘌呤喂养后切换为正常饮食 4 周后,对照组的 sCr 和 BUN 仍然很高,血清 IS 进一步增加。此外,对照组的肾小管间质纤维化面积增加。另一方面,3.0-Lac 和 7.5-Lac 组改善了 sCr 和 BUN 水平,并抑制了肾小管间质纤维化,表明乳果糖可预防 CKD 进展。Lac 组还降低了血清 IS 水平和产生 IS 前体的肠道微生物群的比例。

结论

乳果糖通过抑制尿毒症毒素的产生来改变肠道微生物群并改善 CKD 进展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0f9/6555783/3d01525f9042/10157_2019_1727_Fig7a_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0f9/6555783/fed8b4cc9eba/10157_2019_1727_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0f9/6555783/04e061ac984e/10157_2019_1727_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0f9/6555783/5e4b2c516d3b/10157_2019_1727_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0f9/6555783/7a71017eb63e/10157_2019_1727_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0f9/6555783/60ce88b915ea/10157_2019_1727_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0f9/6555783/da3b80f0fcca/10157_2019_1727_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0f9/6555783/3d01525f9042/10157_2019_1727_Fig7a_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0f9/6555783/fed8b4cc9eba/10157_2019_1727_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0f9/6555783/04e061ac984e/10157_2019_1727_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0f9/6555783/5e4b2c516d3b/10157_2019_1727_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0f9/6555783/7a71017eb63e/10157_2019_1727_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0f9/6555783/60ce88b915ea/10157_2019_1727_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0f9/6555783/da3b80f0fcca/10157_2019_1727_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0f9/6555783/3d01525f9042/10157_2019_1727_Fig7a_HTML.jpg

相似文献

1
Effects of lactulose on renal function and gut microbiota in adenine-induced chronic kidney disease rats.乳果糖对腺嘌呤诱导的慢性肾脏病大鼠肾功能和肠道微生物群的影响。
Clin Exp Nephrol. 2019 Jul;23(7):908-919. doi: 10.1007/s10157-019-01727-4. Epub 2019 Mar 20.
2
Effects of prebiotic oligofructose-enriched inulin on gut-derived uremic toxins and disease progression in rats with adenine-induced chronic kidney disease.低聚果糖富集菊粉对腺嘌呤诱导的慢性肾病大鼠肠道来源尿毒症毒素及疾病进展的影响。
PLoS One. 2021 Oct 6;16(10):e0258145. doi: 10.1371/journal.pone.0258145. eCollection 2021.
3
Microbiota issue in CKD: how promising are gut-targeted approaches?慢性肾脏病中的微生物组问题:肠道靶向治疗方法有多大潜力?
J Nephrol. 2019 Feb;32(1):27-37. doi: 10.1007/s40620-018-0516-0. Epub 2018 Aug 1.
4
Alteration of the Intestinal Environment by Lubiprostone Is Associated with Amelioration of Adenine-Induced CKD.鲁比前列酮对肠道环境的改变与腺嘌呤诱导的慢性肾脏病的改善相关。
J Am Soc Nephrol. 2015 Aug;26(8):1787-94. doi: 10.1681/ASN.2014060530. Epub 2014 Dec 18.
5
Emodin via colonic irrigation modulates gut microbiota and reduces uremic toxins in rats with chronic kidney disease.大黄素通过结肠灌洗调节慢性肾脏病大鼠的肠道微生物群并降低尿毒症毒素。
Oncotarget. 2016 Apr 5;7(14):17468-78. doi: 10.18632/oncotarget.8160.
6
The guanylate cyclase C agonist linaclotide ameliorates the gut-cardio-renal axis in an adenine-induced mouse model of chronic kidney disease.鸟苷酸环化酶 C 激动剂利那洛肽可改善腺嘌呤诱导的慢性肾脏病小鼠模型中的肠道-心脏-肾脏轴。
Nephrol Dial Transplant. 2020 Feb 1;35(2):250-264. doi: 10.1093/ndt/gfz126.
7
The Impact of CKD on Uremic Toxins and Gut Microbiota.慢性肾脏病对尿毒症毒素和肠道微生物群的影响。
Toxins (Basel). 2021 Mar 31;13(4):252. doi: 10.3390/toxins13040252.
8
Dietary Changes Involving Bifidobacterium longum and Other Nutrients Delays Chronic Kidney Disease Progression.饮食改变涉及长双歧杆菌和其他营养物质可延缓慢性肾脏病进展。
Am J Nephrol. 2018;47(5):325-332. doi: 10.1159/000488947. Epub 2018 May 18.
9
The Effect of ß-Glucan Prebiotic on Kidney Function, Uremic Toxins and Gut Microbiome in Stage 3 to 5 Chronic Kidney Disease (CKD) Predialysis Participants: A Randomized Controlled Trial.β-葡聚糖益生元对 3 至 5 期慢性肾脏病(CKD)透析前患者肾功能、尿毒症毒素和肠道微生物组的影响:一项随机对照试验。
Nutrients. 2022 Feb 14;14(4):805. doi: 10.3390/nu14040805.
10
Phosphate binders prevent phosphate-induced cellular senescence of vascular smooth muscle cells and vascular calcification in a modified, adenine-based uremic rat model.在一种改良的、基于腺嘌呤的尿毒症大鼠模型中,磷酸盐结合剂可预防磷酸盐诱导的血管平滑肌细胞衰老和血管钙化。
Calcif Tissue Int. 2015 Apr;96(4):347-58. doi: 10.1007/s00223-014-9929-5. Epub 2014 Dec 16.

引用本文的文献

1
Fecal microbiota transplantation is a promising therapy for kidney diseases.粪便微生物群移植是一种很有前景的肾脏疾病治疗方法。
Front Med (Lausanne). 2025 Jul 9;12:1628722. doi: 10.3389/fmed.2025.1628722. eCollection 2025.
2
One of the Short-Chain Fatty Acids (SCFAs), Sodium Propionate, Can Reduce the Dosage of Sishen Pill in Regulating the Intestinal Microbiota in Diarrhea with Kidney-Yang Deficiency Syndrome.短链脂肪酸之一的丙酸钠可降低四神丸在肾阳虚证腹泻中调节肠道菌群的剂量。
J Inflamm Res. 2025 Jun 5;18:7195-7214. doi: 10.2147/JIR.S522689. eCollection 2025.
3
Gut microbiota-targeted therapies in pediatric chronic kidney disease: gaps and opportunities.

本文引用的文献

1
Homocysteine Aggravates Intestinal Epithelial Barrier Dysfunction in Rats with Experimental Uremia.同型半胱氨酸加重实验性尿毒症大鼠的肠上皮屏障功能障碍
Kidney Blood Press Res. 2018;43(5):1516-1528. doi: 10.1159/000494018. Epub 2018 Oct 18.
2
Impact of the Oral Adsorbent AST-120 on Organ-Specific Accumulation of Uremic Toxins: LC-MS/MS and MS Imaging Techniques.口服吸附剂 AST-120 对尿毒症毒素在特定器官蓄积的影响:LC-MS/MS 和 MS 成像技术。
Toxins (Basel). 2017 Dec 28;10(1):19. doi: 10.3390/toxins10010019.
3
Dose-Dependent Prebiotic Effect of Lactulose in a Computer-Controlled In Vitro Model of the Human Large Intestine.
儿童慢性肾脏病中针对肠道微生物群的疗法:差距与机遇
Pediatr Nephrol. 2025 May 1. doi: 10.1007/s00467-025-06789-z.
4
The Gut-Kidney Axis in Chronic Kidney Diseases.慢性肾脏病中的肠-肾轴
Diagnostics (Basel). 2024 Dec 25;15(1):21. doi: 10.3390/diagnostics15010021.
5
Camellia sinensis methanolic leaves extract: Phytochemical analysis and anticancer activity against human liver cancer cells.茶树甲醇叶提取物:化学成分分析及对人肝癌细胞的抗癌活性。
PLoS One. 2024 Nov 14;19(11):e0309795. doi: 10.1371/journal.pone.0309795. eCollection 2024.
6
7-Phenylheptanoic Acid-Hydroxypropyl β-Cyclodextrin Complex Slows the Progression of Renal Failure in Adenine-Induced Chronic Kidney Disease Mice.7-苯庚酸-羟丙基-β-环糊精复合物可减缓腺嘌呤诱导的慢性肾病小鼠肾功能衰竭的进展。
Toxins (Basel). 2024 Jul 12;16(7):316. doi: 10.3390/toxins16070316.
7
Real-world evidence of constipation and laxative use in the Korean population with chronic kidney disease from a common data model.真实世界证据:韩国慢性肾脏病患者的便秘和泻药使用情况。
Sci Rep. 2024 Mar 19;14(1):6610. doi: 10.1038/s41598-024-57382-7.
8
Canagliflozin attenuates kidney injury, gut-derived toxins, and gut microbiota imbalance in high-salt diet-fed Dahl salt-sensitive rats.坎格列净可减轻高盐饮食喂养的 Dahl 盐敏感大鼠的肾脏损伤、肠道来源的毒素和肠道微生物群落失衡。
Ren Fail. 2024 Dec;46(1):2300314. doi: 10.1080/0886022X.2023.2300314. Epub 2024 Jan 8.
9
Early diagnosis of aortic calcification through dental X-ray examination for dental pulp stones.通过牙髓结石的牙科 X 射线检查进行主动脉钙化的早期诊断。
Sci Rep. 2023 Oct 30;13(1):18576. doi: 10.1038/s41598-023-45902-w.
10
Constipation in Patients With Chronic Kidney Disease.慢性肾脏病患者的便秘
J Neurogastroenterol Motil. 2023 Oct 30;29(4):428-435. doi: 10.5056/jnm23133.
乳果糖在人体大肠计算机控制体外模型中的剂量依赖性益生元效应。
Nutrients. 2017 Jul 18;9(7):767. doi: 10.3390/nu9070767.
4
Key Role for the Organic Anion Transporters, OAT1 and OAT3, in the in vivo Handling of Uremic Toxins and Solutes.有机阴离子转运体 OAT1 和 OAT3 在体内处理尿毒症毒素和溶质中的关键作用。
Sci Rep. 2017 Jul 10;7(1):4939. doi: 10.1038/s41598-017-04949-2.
5
Evaluation of the impact of gut microbiota on uremic solute accumulation by a CE-TOFMS-based metabolomics approach.基于 CE-TOFMS 的代谢组学方法评价肠道微生物群对尿毒症溶质积累的影响。
Kidney Int. 2017 Sep;92(3):634-645. doi: 10.1016/j.kint.2017.02.011. Epub 2017 Apr 8.
6
Modulation of a Circulating Uremic Solute via Rational Genetic Manipulation of the Gut Microbiota.通过对肠道微生物群进行合理的基因操作来调节循环中的尿毒症溶质。
Cell Host Microbe. 2016 Dec 14;20(6):709-715. doi: 10.1016/j.chom.2016.10.021. Epub 2016 Dec 1.
7
Chronic Kidney Disease.慢性肾脏病。
Lancet. 2017 Mar 25;389(10075):1238-1252. doi: 10.1016/S0140-6736(16)32064-5. Epub 2016 Nov 23.
8
Chronic kidney disease induced by adenine: a suitable model of growth retardation in uremia.腺嘌呤诱导的慢性肾脏病:一种适用于尿毒症生长迟缓的模型
Am J Physiol Renal Physiol. 2015 Jul 1;309(1):F57-62. doi: 10.1152/ajprenal.00051.2015. Epub 2015 May 13.
9
Alteration of the Intestinal Environment by Lubiprostone Is Associated with Amelioration of Adenine-Induced CKD.鲁比前列酮对肠道环境的改变与腺嘌呤诱导的慢性肾脏病的改善相关。
J Am Soc Nephrol. 2015 Aug;26(8):1787-94. doi: 10.1681/ASN.2014060530. Epub 2014 Dec 18.
10
Correlation between Serum Levels of Protein-Bound Uremic Toxins in Hemodialysis Patients Measured by LC/MS/MS.采用液相色谱-串联质谱法测定血液透析患者血清中蛋白结合尿毒症毒素水平的相关性
Mass Spectrom (Tokyo). 2013;2(Spec Iss):S0017. doi: 10.5702/massspectrometry.S0017. Epub 2013 Apr 15.